Fadi Farhat

1.1k total citations
51 papers, 551 citations indexed

About

Fadi Farhat is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fadi Farhat has authored 51 papers receiving a total of 551 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 24 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Fadi Farhat's work include Cancer Treatment and Pharmacology (16 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). Fadi Farhat is often cited by papers focused on Cancer Treatment and Pharmacology (16 papers), Cancer Genomics and Diagnostics (9 papers) and Colorectal Cancer Treatments and Studies (9 papers). Fadi Farhat collaborates with scholars based in Lebanon, France and United States. Fadi Farhat's co-authors include Joseph Kattan, Marwan Ghosn, Ali Shamseddine, Elie Rassy, Tarek Assi, Georges Chahine, Fadi Nasr, Fadi El Karak, Areej Othman and Christine Théodore and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Fadi Farhat

47 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fadi Farhat Lebanon 13 296 218 107 87 78 51 551
Alannah Smrke United Kingdom 11 238 0.8× 160 0.7× 62 0.6× 117 1.3× 51 0.7× 31 516
Dimitrios Mantas Greece 16 263 0.9× 134 0.6× 94 0.9× 147 1.7× 105 1.3× 75 768
Nada Riva Italy 16 362 1.2× 271 1.2× 47 0.4× 84 1.0× 50 0.6× 32 592
Branko Cuglievan United States 14 207 0.7× 130 0.6× 40 0.4× 121 1.4× 78 1.0× 79 562
Shripad Banavali India 13 145 0.5× 180 0.8× 39 0.4× 67 0.8× 104 1.3× 37 483
Lore Lapeire Belgium 11 202 0.7× 130 0.6× 96 0.9× 135 1.6× 25 0.3× 41 464
Cono Scaffa Italy 21 157 0.5× 102 0.5× 86 0.8× 152 1.7× 61 0.8× 70 1.2k
Luísa Pinto Portugal 7 352 1.2× 152 0.7× 48 0.4× 120 1.4× 52 0.7× 26 704
Hyewon Ryu South Korea 16 245 0.8× 146 0.7× 58 0.5× 131 1.5× 39 0.5× 65 614
S. Bennis Morocco 15 198 0.7× 94 0.4× 124 1.2× 139 1.6× 104 1.3× 52 600

Countries citing papers authored by Fadi Farhat

Since Specialization
Citations

This map shows the geographic impact of Fadi Farhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fadi Farhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fadi Farhat more than expected).

Fields of papers citing papers by Fadi Farhat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fadi Farhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fadi Farhat. The network helps show where Fadi Farhat may publish in the future.

Co-authorship network of co-authors of Fadi Farhat

This figure shows the co-authorship network connecting the top 25 collaborators of Fadi Farhat. A scholar is included among the top collaborators of Fadi Farhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fadi Farhat. Fadi Farhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kourié, Hampig Raphaël, Lewis Nasr, Fadi El Karak, et al.. (2024). Liquid biopsy as a tool for KRAS/NRAS/BRAF baseline testing in metastatic colorectal cancer. Clinics and Research in Hepatology and Gastroenterology. 48(8). 102417–102417. 1 indexed citations
2.
3.
Ibrahim, Tony, Elie Rassy, Fadi El Karak, et al.. (2020). Comprehensive tumor profiling-guided therapy in rare or refractory solid cancer: A feasibility study in daily clinical practice. Bulletin du Cancer. 107(4). 410–416.
4.
Assi, Tarek, Elie Rassy, Fadi Farhat, et al.. (2020). TRK inhibition in soft tissue sarcomas: A comprehensive review. Seminars in Oncology. 47(1). 73–84. 8 indexed citations
5.
Assi, Tarek, Elie Rassy, Fadi Farhat, & Joseph Kattan. (2019). Overview on the role of preoperative therapy in the management of kidney cancer. Clinical & Translational Oncology. 22(1). 11–20. 5 indexed citations
6.
Assi, Tarek, Joseph Kattan, Elie Rassy, et al.. (2018). Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experience. Journal of Cancer Research and Therapeutics. 14(5). 1112–1116. 2 indexed citations
7.
Rassy, Elie, Marwan Ghosn, Fadi Farhat, et al.. (2018). Toxicities Associated with Docetaxel-Based Regimens in the Adjuvant Treatment of Early-Stage Breast Cancer: A Multicenter Prospective Real-Life Experience. Breast Care. 13(2). 119–123. 2 indexed citations
8.
Karak, Fadi El, Ibrahim R. Bou-Orm, Marwan Ghosn, et al.. (2017). PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma. PLoS ONE. 12(1). e0170299–e0170299. 22 indexed citations
9.
Kourié, Hampig Raphaël, et al.. (2016). Watch and Wait in Lebanese Chronic Lymphocytic Leukemia Patients: How Relevant is it?. Asian Pacific Journal of Cancer Prevention. 17(1). 215–217. 3 indexed citations
10.
Kattan, Joseph, et al.. (2016). Phase II trial of weekly Docetaxel, Zoledronic acid, and Celecoxib for castration-resistant prostate cancer. Investigational New Drugs. 34(4). 474–480. 9 indexed citations
11.
Assi, Tarek, Elie Rassy, Tony Ibrahim, et al.. (2016). The role of palliative care in the last month of life in elderly cancer patients. Supportive Care in Cancer. 25(2). 599–605. 6 indexed citations
12.
Assi, Tarek, Elie Rassy, Tony Ibrahim, et al.. (2016). Characteristics of Gastric Cancer in Lebanon: a Descriptive Study from a Single Institutional Experience. Journal of Gastrointestinal Cancer. 49(1). 21–24. 8 indexed citations
13.
Farhat, Fadi, Joseph Kattan, & Marwan Ghosn. (2016). Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer. Cancer Chemotherapy and Pharmacology. 77(5). 1069–1077. 9 indexed citations
14.
Assi, Tarek, Elie Rassy, Samer Tabchi, et al.. (2015). Treatment of cancer patients in their last month of life: aimless chemotherapy. Supportive Care in Cancer. 24(4). 1603–1608. 24 indexed citations
15.
16.
Pierce, Matthew, et al.. (2014). Hypertension induced by chemotherapeutic and immunosuppresive agents: A new challenge. Critical Reviews in Oncology/Hematology. 93(1). 28–35. 30 indexed citations
17.
Shamseddine, Ali, et al.. (2012). High-Dose Calcitriol, Docetaxel and Zoledronic Acid in Patients with Castration-Resistant Prostate Cancer: A Phase II Study. Urologia Internationalis. 90(1). 56–61. 10 indexed citations
18.
Ghosn, Marwan, Carla Hajj, Joseph Kattan, et al.. (2011). Triple-Negative Breast Cancer in Lebanon: A Case Series. The Oncologist. 16(11). 1552–1556. 10 indexed citations
19.
Shamseddine, Ali & Fadi Farhat. (2011). Platinum-Based Compounds for the Treatment of Metastatic Breast Cancer. Chemotherapy. 57(6). 468–487. 44 indexed citations
20.
Élias, D., et al.. (1993). [Triple hepatectomy for cancer].. PubMed. 130(3). 107–10. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alannah Smrke Breakdown of academic impact, for papers by Dimitrios Mantas Breakdown of academic impact, for papers by Nada Riva Breakdown of academic impact, for papers by Branko Cuglievan Breakdown of academic impact, for papers by Shripad Banavali Breakdown of academic impact, for papers by Lore Lapeire Breakdown of academic impact, for papers by Cono Scaffa Breakdown of academic impact, for papers by Luísa Pinto Breakdown of academic impact, for papers by Hyewon Ryu Breakdown of academic impact, for papers by S. Bennis
Rankless by CCL
2026